Topline results reported from phase II study of REL-1017 in treatment-resistant depression Oct. 16, 2019
Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS Oct. 15, 2019
Primary endpoint met in registrational MOXIe trial of omaveloxolone for Friedreich's ataxia Oct. 15, 2019
Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists Oct. 15, 2019
Novel phenylpropanoid analogue promotes neurogenesis, ameliorates cognitive impairment in AD models Oct. 14, 2019
RSS